Term
|
Definition
multiphasic: uses both phenotype and genotype to classify
phenotypic classification more likely to relate to disease |
|
|
Term
|
Definition
polymer of n-acetyl muramic acid (NAM) and n-acetyl glucosamine (NAG), peptide side chain
NAG and NAM are linked by glysosidic bond
adjacent peptidoglycan polymers are crosslinked by peptide side chains
makes up 80% of cell mass
retains cell shape
gives cell staining qualities (GRAM)
provides osmotic stability to cell wall |
|
|
Term
peptidoglycan cross linking |
|
Definition
interpeptide bridge made of amino acids
attach to penultimate (second to last) amino acid on NAM peptide chain
The terminal (last) amino acid is cleaved
this provides high energy to the bond, making peptidoglycan very strong
in Gram + there are 5 Gly connecting 2 NAM chains
in Gram -, lysine connects directly to alanine on the chains |
|
|
Term
penicillin and peptidoglycan |
|
Definition
penicillan prevents the cross linking between adjacent NAG/NAM ploymers |
|
|
Term
enzymes attacking peptidoglycan |
|
Definition
cleave subunits of peptidoglycan to lyse the cell wall
can attack at different locations
example: lysozyme cleaves glycosidic linkage b/w NAG and NAM |
|
|
Term
Gram + and negative: extra info |
|
Definition
Gram + withstands more osmotic pressure b/c of the larger peptidoglycan layer
teichoic acids are covalently linked to PG layer |
|
|
Term
teichoic, lipoteichoic acids |
|
Definition
cation regulation (important for gram staining)
antigenic and unique to the organism |
|
|
Term
LPS: core polysaccharide (oligosaccharide) vs terminal polysaccharide |
|
Definition
core oligosaccharide is highly conserved among bacterial species (not unique)
terminal polysaccharide is extermely unique (varies from strain to strain) and produces antigenic response (O antigen) |
|
|
Term
|
Definition
aid in identification of organisms
consists of particles like nutrients, metabolic products
can be seen as uneven staining (beaded filaments)
|
|
|
Term
|
Definition
antibody creates a visible halo around colonies when capsule is present |
|
|
Term
capsule and immune response |
|
Definition
avoid recognition by PHAGOCYTES
poor immunogens
when capsular antibodies are present in an animal they act as OPSONINS that facilitate phagocytic recognition of encapsulated organisms |
|
|
Term
|
Definition
modified: provides enzyme resistance |
|
|
Term
measurement of microbial growth |
|
Definition
turbidometric: measures turbidity of solution. will count both dead and live cells
CFU (colony forming units) uses a culture, so only live bacteria are counted |
|
|
Term
|
Definition
agar is only a support medium, it does not provide nutrients
agarose is agar with added sugar (nutrients) |
|
|
Term
reactive oxygen species and enzymes |
|
Definition
superoxide: superoxide dismutase
hydrogen peroxide (or other peroxides): peroxidase, catalase
|
|
|
Term
|
Definition
prefer live animals if possible
select a site most likely to contain the pathogen
minimize contamination |
|
|
Term
|
Definition
want to limit growth
move it quickly
use non nutritive media
control environmental conditions (most and cool)
safety: no splashy |
|
|
Term
antibiotic vs antimicrobial, chemotherapeutic |
|
Definition
antibiotic: produced by a living organism
antimicrobial: any substance that inhibits microbes including man made / synthetic
chemotherapeutic agent: antimicrobial used to treat a disease |
|
|
Term
structure of antimicrobial chemotherapeutics |
|
Definition
hapten like: can't create an immune response on its own, if response is produced then antibody recognises it
binds to another molecule to create response? |
|
|
Term
|
Definition
attack folic acid producing cells
mammals can't synthesize folic acid
selective toxicity |
|
|
Term
|
Definition
MIC minimum inhibitory concentration: minimum conc that inhibits all growth (original organisms may still be alive)
MBC minimum bacteriocidal concentration: minimum conc where bacteria are killed
anitbiotics are bactericidal if MBC is no more than 4x MIC (don't have to kill at same point as growth inhibition to be bactericidal) |
|
|
Term
why is it difficult to treat kidney infections with cell wall attacking antibiotics? |
|
Definition
The fluids in the kidney are about isotonic to the bacterial cells
the only reason cell wall break down works is because it makes the cell vulnerable to osmotic pressure
if there is not enough osmotic pressure to lyse the cell then it will not die |
|
|
Term
|
Definition
there is a bell curve that represents concentration of drug in the body over time: the drug will be expelled from the body after reaching a peak concentration / distribution
the peak concentration must be above MIC for drug therapy to be successful
for concentration dependent drugs: must dose to reach certain cmx; time may not be important
for time dependent drugs: dosages must overlap to keep CMAX over MIC for required period
use AUC (area under conc curve) to MIC ratio to determine dose adjustment |
|
|
Term
|
Definition
conjugative: encode the F factor (sex pilus) and can transfer itself
mobilizable: does not encode F factor but can be transferred by another plasmid that does; hitch a ride
non conjugative: is not transferred horizontally. might be replicated when cell does binary fission
|
|
|
Term
bacterial variation methods (could relate to resistance) |
|
Definition
Phenotypic change
transcriptional: substrate alteration
post transcritional: proteolysis, covalent modifications
Genotypic change
modify existing DNA: mutations and mobile elements (selective pressure favors good genes)
acquire new DNA: horizontal transfer
|
|
|
Term
why do pathogens bother with infecting the body when they could just avoid the immune system by staying outside? |
|
Definition
the inside of the body is an ecological niche
many organisms occupy the outside but few are viable inside
these few can have a large share of the nutrients found in the body as long as they can avoid immunity |
|
|
Term
|
Definition
blocks of DNA with signatures of mobile genetic elements
mobile genes can inactivate genes located at their target location |
|
|
Term
|
Definition
resistance is always present in some subset of the population
it only becomes an issue if these bacteria get in the right situation and get positive selective pressure so that they become prevalent |
|
|
Term
why are normal flora not pathogenic? |
|
Definition
they are not able to penetrate the host's barriers: lack virulence factors |
|
|
Term
why is LPS not easily neutralized by the immune system? |
|
Definition
the antigen is located on the terminal polysaccharide
the immune system does not target Lipid A
Lipid A is the toxic part |
|
|
Term
|
Definition
A: catalytic domain: alters the target with enzymes
B: binding domain / receptor
AB proteins must be activated by "nicking" after they leave the bacterial cell
If they become active inside the bacterial cell it will attack the cell
it's like a grenade - the pin has to be pulled first to work otherwise it blows up on you |
|
|
Term
Levels of infection / progression |
|
Definition
locally non invasive: skin, some diarrheal
locally invasive: cellulitis, pharyngitis
deeply invasive: septicemia, meningitis, osteomyelitis
intoxication and toxemia
shock: toxic/septic/endotoxic (LPS)
death or recovery
post infection: sequelae
|
|
|
Term
choosing sensitivity vs specificity |
|
Definition
sensitive tests are broader spectrum, used for screening
specific tests are narrower spectrum, could be used to verify a positive from the more sensitive test |
|
|